Walle Thomas
Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC 29425, USA.
Free Radic Biol Med. 2004 Apr 1;36(7):829-37. doi: 10.1016/j.freeradbiomed.2004.01.002.
The benefits of flavonoids as chemopreventive dietary or dietary supplemental agents are still only "potential." Much has been learned about possible mechanisms of action of these agents, but whether they can reach their multiple intended sites of action, particularly in humans, is largely unknown. The biological fate of the flavonoids, including their dietary glycoside forms, is highly complex, dependent on a large number of processes. This review is intended to bring some order into this complex area and deals with the fate of the naturally occurring glycosides, their enzymatic hydrolysis, as well as the resulting aglycones. The impact of membrane transporters as well as metabolic enzymes on the cellular availability of these phytochemicals is examined. A reevaluation of the concept of oral bioavailability applied to the dietary flavonoids is presented.
类黄酮作为化学预防膳食或膳食补充剂的益处仍只是“潜在的”。关于这些物质可能的作用机制我们已了解很多,但它们能否到达多个预期作用部位,尤其是在人体中,很大程度上尚不清楚。类黄酮的生物学命运,包括其膳食糖苷形式,非常复杂,取决于大量过程。本综述旨在梳理这一复杂领域,探讨天然存在的糖苷的命运、它们的酶促水解以及由此产生的苷元。研究了膜转运蛋白和代谢酶对这些植物化学物质细胞可利用性的影响。还对应用于膳食类黄酮的口服生物利用度概念进行了重新评估。